Alnylam Pharmaceuticals, Inc. vs Comfort Systems USA Inc — how do they compare? Alnylam Pharmaceuticals, Inc. trades at $221.5 (market cap $29.60B), while Comfort Systems USA Inc trades at $1,710.98 (market cap $59.41B). The key difference: Comfort Systems USA Inc is far larger — about 2× Alnylam Pharmaceuticals, Inc.'s market cap, and Comfort Systems USA Inc pays a 0.21% dividend while Alnylam Pharmaceuticals, Inc. pays none. Which is the better fit depends on your goals.
| ALNY | FIX | |
|---|---|---|
Market Cap | $29.60B | $59.41B |
Sector | Health | Technology |
52-Week High | $491.22 | $2.07K |
52-Week Low | $205.48 | $680.86 |
Enterprise Value | $27.56B | $57.88B |
Dividend Yield | — | 0.21% |
Trailing returns across standard periods
Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics. RNAi is a naturally occurring biological pathway within cells for sequence-specific silencing and regulation of gene expression. Alnylam has five drugs on the market: Onpattro and Amvuttra for hATTR amyloidosis, Givlaari for acute hepatic porphyria, Oxlumo for primary hyperoxaluria type 1, and Leqvio for hypercholesterolemia.
Read more on ALNY →Comfort Systems USA is a premier provider of mechanical and electrical contracting services. It specializes in HVAC, plumbing, and energy management solutions for commercial and industrial facilities.
Read more on FIX →